It is important to note that LRRK2 is a risk factor, not a primary cause of PD, and, according to Taymans et al., “the end goal of validating LRRK2 as a PD therapeutic target has yet to be reached” [144]. The gene discussed is LRRK2; the disease is Parkinson disease.